Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
NOVADAQ TECHNOLOGIES INC (NVDQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/11/2017 6-K Quarterly results
09/01/2017 6-K Quarterly results
08/10/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K-Q2-FS",
"Interim Unaudited Consolidated Financial Statements",
"Management’s Discussion and Analysis",
"CEO Certification",
"CFO Certification"
08/09/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"NOVADAQ Receives Court Approval for Arrangement With Stryker"
08/04/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Novadaq Announces Voting Results of Special Meeting of Shareholders"
07/24/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/12/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
07/12/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
06/20/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/20/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/19/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/07/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/04/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/03/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/19/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/01/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/28/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/15/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/08/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01/19/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01/10/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01/04/2017 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
12/06/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/22/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/08/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Docs: "FORM 6-K",
"NOVADAQ to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum TORONTO, Nov. 08, 2016 -- NOVADAQ Technologies Inc. , the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, President and Chief Executive Officer, is scheduled to present at the Canaccord Genuity Medical Technologies and Diagnostics Forum on Thursday, November 17 th at 1:00 p.m. Eastern Time at the Westin Grand Central in . A live webcast of the presentation can be accessed on the company’s website at www.novadaq.com under the “Events” tab in the “Investors” section. Following the meeting, the presentation will be archived on the website for 90 days. NOVADAQ’s global mission is to enable ..."
11/03/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/02/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
10/07/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Docs: "FORM 6-K",
"NOVADAQ to Host Analyst and Investor Day on November 14, 2016 TORONTO, Oct. 05, 2016 -- NOVADAQ Technologies Inc. , the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November 14, 2016. The event will be held at the Sofitel Hotel in from 9:00 a.m. to approximately 12:00 p.m. Eastern Time. The program will feature presentations given by Rick Mangat, NOVADAQ’s President and Chief Executive Officer, and Roger Deck, Chief Financial Officer. In addition, members of the NOVADAQ executive team will provide updates on the Company’s business. Advance registration is required for the event and space may be limited. Those wishing to attend the live event should register..."
09/06/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/25/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Docs: "FORM 6-K",
"About NOVADAQ Technologies Inc. NOVADAQ's global mission is to enable physicians with point-of-care imaging solutions that provide real time clinically significant and actionable information to improve care quality and lower healthcare costs. Using NOVADAQ's SPY fluorescence imaging technology, physicians can personalize therapy and achieve optimal results through the precise visualization of blood flow in vessels, micro-vessels, tissue perfusion and critical anatomical structures during the course of treatment. SPY technology enables the delivery of personalized therapies and the achievement of the optimal results for each individual patient. More than 210 peer-reviewed publications demonstrate that the use of SPY technology will reduce post-procedure complication rates and the cost of ca..."
07/29/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
07/28/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
07/27/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
07/11/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy